DOCSLIB.ORG

Tracerx Consortium Members

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Tracerx Consortium Members TRACERx Consortium Members Name Site/Institution Jason Lester Swansea Bay University Health Board, Swansea, Wales Fiona Morgan Cardiff & Vale University Health Board, Cardiff, Wales Malgorzata Kornaszewska Cardiff & Vale University Health Board, Cardiff, Wales Richard Attanoos Cardiff & Vale University Health Board, Cardiff, Wales Haydn Adams Cardiff & Vale University Health Board, Cardiff, Wales Helen Davies Cardiff & Vale University Health Board, Cardiff, Wales Cancer Research Centre, University of Leicester, Leicester, United Kingdom & Leicester University Hospitals, Dean Fennell Leicester, United Kingdom Apostolos Nakas Leicester University Hospitals, Leicester, United Kingdom Sridhar Rathinam Leicester University Hospitals, Leicester, United Kingdom Rachel Plummer Leicester University Hospitals, Leicester, United Kingdom Rebecca Boyles Leicester University Hospitals, Leicester, United Kingdom Mohamad Tufail Leicester University Hospitals, Leicester, United Kingdom Amrita Bajaj Leicester University Hospitals, Leicester, United Kingdom Jan Brozik Leicester University Hospitals, Leicester, United Kingdom National Institute for Health Research Leicester Respiratory Biomedical Research Unit, Leicester, United William Monteiro Kingdom National Institute for Health Research Leicester Respiratory Biomedical Research Unit, Leicester, United Hilary Marshall Kingdom Alan Dawson University of Leicester, Leicester, United Kingdom Sara Busacca University of Leicester, Leicester, United Kingdom Domenic Marrone University of Leicester, Leicester, United Kingdom Keng Ang Leicester University Hospitals, Leicester, United Kingdom Mohammed Fiyaz Chowdhry Leicester University Hospitals, Leicester, United Kingdom Claire Smith University of Leicester, Leicester, United Kingdom Jacqui Shaw Cancer Research Centre, University of Leicester, Leicester, United Kingdom Joan Riley Cancer Research Centre, University of Leicester, Leicester, United Kingdom Lindsay Primrose Cancer Research Centre, University of Leicester, Leicester, United Kingdom Girija Anand Barnet & Chase Farm Hospitals, United Kingdom Sajid Khan Barnet & Chase Farm Hospitals, United Kingdom Gillian Price Aberdeen Royal Infirmary, Aberdeen, United Kingdom Mohammed Khalil Aberdeen Royal Infirmary, Aberdeen, United Kingdom Keith Kerr Aberdeen Royal Infirmary, Aberdeen, United Kingdom Shirley Richardson Aberdeen Royal Infirmary, Aberdeen, United Kingdom Heather Cheyne Aberdeen Royal Infirmary, Aberdeen, United Kingdom Joy Miller Aberdeen Royal Infirmary, Aberdeen, United Kingdom Keith Buchan Aberdeen Royal Infirmary, Aberdeen, United Kingdom Mahendran Chetty Aberdeen Royal Infirmary, Aberdeen, United Kingdom Sylvie Dubois-Marshall Aberdeen Royal Infirmary, Aberdeen, United Kingdom Sara Lock The Whittington Hospital NHS Trust, London, United Kingdom Kayleigh Gilbert The Whittington Hospital NHS Trust, London, United Kingdom Babu Naidu University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom Gerald Langman University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom Hollie Bancroft University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom Salma Kadiri University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom Gary Middleton University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom Madava Djearaman University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom Aya Osman University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom Helen Shackleford University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom Akshay Patel University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom Angela leek Manchester Cancer Research Centre Biobank, Manchester, United Kingdom Nicola Totten Manchester Cancer Research Centre Biobank, Manchester, United Kingdom Jack Davies Hodgkinson Manchester Cancer Research Centre Biobank, Manchester, United Kingdom Jane Rogan Manchester Cancer Research Centre Biobank, Manchester, United Kingdom Katrina Moore Manchester Cancer Research Centre Biobank, Manchester, United Kingdom Rachael Waddington Manchester Cancer Research Centre Biobank, Manchester, United Kingdom Yvonne Summers Wythenshawe Hospital, Manchester University NHS Foundation Trust Raffaele Califano Wythenshawe Hospital, Manchester University NHS Foundation Trust Rajesh Shah Wythenshawe Hospital, Manchester University NHS Foundation Trust Piotr Krysiak Wythenshawe Hospital, Manchester University NHS Foundation Trust Kendadai Rammohan Wythenshawe Hospital, Manchester University NHS Foundation Trust Eustace Fontaine Wythenshawe Hospital, Manchester University NHS Foundation Trust Richard Booton Wythenshawe Hospital, Manchester University NHS Foundation Trust Matthew Evison Wythenshawe Hospital, Manchester University NHS Foundation Trust Stuart Moss Wythenshawe Hospital, Manchester University NHS Foundation Trust Juliette Novasio Wythenshawe Hospital, Manchester University NHS Foundation Trust Leena Joseph Wythenshawe Hospital, Manchester University NHS Foundation Trust Paul Bishop Wythenshawe Hospital, Manchester University NHS Foundation Trust Anshuman Chaturvedi Wythenshawe Hospital, Manchester University NHS Foundation Trust Helen Doran Wythenshawe Hospital, Manchester University NHS Foundation Trust Felice Granato Wythenshawe Hospital, Manchester University NHS Foundation Trust Vijay Joshi Wythenshawe Hospital, Manchester University NHS Foundation Trust Elaine Smith Wythenshawe Hospital, Manchester University NHS Foundation Trust Angeles Montero Wythenshawe Hospital, Manchester University NHS Foundation Trust Wythenshawe Hospital, Manchester University NHS Foundation Trust, Division of Infection, Immunity and Phil Crosbie Respiratory Medicine, University of Manchester, Manchester, UK; Cancer Research UK Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK Katie Baker Christie NHS Foundation Trust, Manchester, United Kingdom Mathew Carter Christie NHS Foundation Trust, Manchester, United Kingdom Colin R Lindsay Christie NHS Foundation Trust, Manchester, United Kingdom Fabio Gomes Christie NHS Foundation Trust, Manchester, United Kingdom Christie NHS Foundation Trust, Manchester, United Kingdom, Cancer Research UK Lung Cancer Centre of Fiona Blackhall Excellence, University of Manchester, Manchester, UK Christie NHS Foundation Trust, Manchester, United Kingdom, Cancer Research UK Lung Cancer Centre of Lynsey Priest Excellence, University of Manchester, Manchester, UK Christie NHS Foundation Trust, Manchester, United Kingdom, Cancer Research UK Lung Cancer Centre of Matthew G Krebs Excellence, University of Manchester, Manchester, UK Jane Rogan Manchester Cancer Research Centre Biobank, Manchester, United Kingdom Jonathan Tugwood Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK Jackie Pierce Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK; Cancer Research UK Caroline Dive Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK; Cancer Research UK Dominic Rothwell Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK; Cancer Research UK Alastair Kerr Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK Alexandra Clipson Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK; Cancer Research UK Elaine Kilgour Lung Cancer Centre of Excellence, University of Manchester, Manchester, UK Berlin Institute for Medical Systems Biology, Max Delbrueck Center for Molecular Medicine, Berlin, Germany Roland Schwarz German Cancer Consortium (DKTK), partner site Berlin German Cancer Research Center (DKFZ), Heidelberg Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Tom L Kaufmann Association (MDC), Robert-Rössle-Str. 10, 13125 Berlin, Germany. BIFOLD, Berlin Institute for the Foundations of Learning and Data, Berlin, Germany. Matthew Huska Berlin Institute for Medical Systems Biology, Max Delbrueck Center for Molecular Medicine, Berlin, Germany Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK;Cancer Nicholas McGranahan Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK;Cancer Evolution and Genome Instability Laboratory, the Francis Crick Institute and University College Charles Swanton London Cancer Institute, London, UK;Department of Medical Oncology, University College London Hospitals, London, United Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, Mariam Jamal-Hanjani UK;Department of Medical Oncology, University College London Hospitals, London, United Zoltan Szallasi Danish Cancer Society Research Center, Denmark Roberto Salgado Department of Pathology, GZA-ZNA Antwerp, Belgium Istvan Csabai Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Budapest, Hungary Miklos Diossy Department of Physics of Complex Systems,
Load more

Recommended publications
  • Vote for Oral Presentations and Posters at 1
    Vote for oral presentations and posters at www.sli.do/HSRUK19 1 Welcome 3 Information 4 Programme 6 Session Summaries 10 Rapid Fire Session Listings 12 Posters 15 Speaker Biographies 20 Exhibitors 24 HSR UK Membership 25 2 Vote for oral presentations and posters at www.sli.do/HSRUK19 WELCOME Welcome to the Health Services Research UK annual conference for 2019 We are delighted to welcome you to the largest and most diverse annual conference that HSR UK has ever organised. Our programme of five plenary sessions, and the dozens of workshops, invited sessions, oral paper presentations and poster presentations over two days are a testament to the growth in health services research over recent years in the United Kingdom, and the existence of a thriving and creative research community. With around 350 people from universities, thinktanks, research funders, NHS organisations, patient and public involvement groups and other stakeholders gathered in Manchester it presents an unparalleled opportunity to see the state of the science in HSR, meet and network with colleague and collaborators. There are awards for the best oral presentations and posters at the conference, and this year we want everyone to contribute by voting for oral presentations and posters that they like – go to www.sli.do/HSRUK19 and enter the 3 digit code beside the presentation or poster in this programme. You can vote for as many different presentations/posters as you like but can only vote once for each one! The awards will be announced at the closing plenary. These are uncertain and difficult times for the NHS in all four countries of the UK, but perhaps particularly in England where the difficult legacy of the Health and Social Care Act 2012 is slowly being unpicked.
    [Show full text]
  • Biology Powerhouse Raises Railway Alarm
    NEWS IN FOCUS to enrol all participants by 2018. Certain factors make researchers optimis- tic that the British study will succeed where the US one failed. One is the National Health Service, which provides care for almost all pregnant women and their children in the United Kingdom, and so offers a centralized means of recruiting, tracing and collecting medical information on study participants. In the United States, by contrast, medical care is provided by a patchwork of differ- ent providers. “I think that most researchers in the US recognize that our way of doing population-based research here is simply different from the way things can be done in the UK and in Europe, and it will almost always be more expensive here,” says Mark Klebanoff, a paediatric epidemiologist at Nationwide Children’s Hospital in Colum- bus, Ohio, who was involved in early dis- cussions about the US study. The Francis Crick Institute sits at the nexus of three central London railway hubs. At one stage, US researchers had planned to knock on doors of random houses looking URBAN SCIENCE for women to enrol before they were even pregnant. “It became obvious that that wasn’t going to be a winning formula,” says Philip Pizzo, a paediatrician at Stanford University Biology powerhouse in Palo Alto, California, who co-chaired the working group that concluded that the National Children’s Study was not feasible. raises railway alarm “The very notion that someone was going to show up on your doorstep as a representa- tive from a govern­ment-funded study and Central London’s Francis Crick Institute fears that proposed say ‘Are you thinking of getting pregnant?’ train line will disrupt delicate science experiments.
    [Show full text]
  • Kettering General Hospital Nhs Foundation Trust in Association with Eastman Dental Hospital and Institute University College London Hospitals Nhs Foundation Trust
    KETTERING GENERAL HOSPITAL NHS FOUNDATION TRUST IN ASSOCIATION WITH EASTMAN DENTAL HOSPITAL AND INSTITUTE UNIVERSITY COLLEGE LONDON HOSPITALS NHS FOUNDATION TRUST SPECIALIST REGISTRAR POST IN ORTHODONTICS JOB DESCRIPTION 2021 APPOINTMENT This job description covers a full-time non-resident Specialist Registrar post in Orthodontics. The duties of this post will be split between Kettering General Hospital and the Eastman Dental Institute, with three days spent in Kettering and two days in the Eastman Dental Institute. This post will be based administratively at the Trent Deanery, Sheffield. The Postgraduate Dental Dean has approved this post for training on advice from the SAC in Orthodontics. The posts have the requisite educational and staffing approval for specialist training leading to a CCST and Specialist Registration with the General Dental Council. The successful candidate will be required to register on the joint training programme leading to the M.Orth.RCS and the MClin.Dent. in Orthodontics at the University of London (unless they already hold equivalent qualifications). This appointment is for one year in the first instance, renewable for a further two years subject to annual review of satisfactory work and progress. Applicants considering applying for this post on a Less Than full Time (flexible training) basis should initially contact the Postgraduate Dental Dean’s office in Sheffield for a confidential discussion. QUALIFICATIONS/EXPERIENCE REQUIRED Applicants for specialist training must be registered with the GDC, fit to practice and able to demonstrate that they have the required broad-based training, experience and knowledge to enter the training programme. Applicants for orthodontics will be expected to have had a broad based training including a period in secondary care, ideally in Oral and Maxillofacial surgery and paediatric dentistry and to have completed a 2 year period of General Professional Training.
    [Show full text]
  • Bloomsbury Scientists Ii Iii
    i Bloomsbury Scientists ii iii Bloomsbury Scientists Science and Art in the Wake of Darwin Michael Boulter iv First published in 2017 by UCL Press University College London Gower Street London WC1E 6BT Available to download free: www.ucl.ac.uk/ ucl- press Text © Michael Boulter, 2017 Images courtesy of Michael Boulter, 2017 A CIP catalogue record for this book is available from the British Library. This book is published under a Creative Commons Attribution Non-commercial Non-derivative 4.0 International license (CC BY-NC-ND 4.0). This license allows you to share, copy, distribute and transmit the work for personal and non-commercial use providing author and publisher attribution is clearly stated. Attribution should include the following information: Michael Boulter, Bloomsbury Scientists. London, UCL Press, 2017. https://doi.org/10.14324/111.9781787350045 Further details about Creative Commons licenses are available at http://creativecommons.org/licenses/ ISBN: 978- 1- 78735- 006- 9 (hbk) ISBN: 978- 1- 78735- 005- 2 (pbk) ISBN: 978- 1- 78735- 004- 5 (PDF) ISBN: 978- 1- 78735- 007- 6 (epub) ISBN: 978- 1- 78735- 008- 3 (mobi) ISBN: 978- 1- 78735- 009- 0 (html) DOI: https:// doi.org/ 10.14324/ 111.9781787350045 v In memory of W. G. Chaloner FRS, 1928– 2016, lecturer in palaeobotany at UCL, 1956– 72 vi vii Acknowledgements My old writing style was strongly controlled by the measured precision of my scientific discipline, evolutionary biology. It was a habit that I tried to break while working on this project, with its speculations and opinions, let alone dubious data. But my old practices of scientific rigour intentionally stopped personalities and feeling showing through.
    [Show full text]
  • Charitable Funds Annual Report 2004/2005
    Charitable Funds Annual Report 2004/2005 Registered charity number 1056452 The Whittington Hospital NHS Trust Charitable Fund Trustees Narendra Makanji Trust Chairman Andrew Riley Chief Executive (until September 2004) David Sloman Chief Executive (from November 2004) Susan Sorensen Director of Finance and Strategic Development Deborah Wheeler Director of Nursing and Clinical Development Margaret Boltwood Director of Human Resources and Corporate Affairs Tara Donnelly Director of Operations Michael Lloyd Director of Site Commissioning Norman Parker Medical Director (until October 2004) Celia Ingham Clark Medical Director (from November 2004) Maria Duggan Non Executive Director Peter Farmer Non Executive Director Pat Gordon Non Executive Director Doreen Henry Non Executive Director Anne Johnson Non Executive Director Michael Worton Non Executive Director (until May 2004) Charity Funds Administration Elizabeth Hall Charitable Funds Accountant Keith Wenden Head of Fundraising Anna Turner Fundraising and Communications Secretary Description of Trusts Although all funds are held within an Umbrella Charity, a small number of funds have their own governing instruments and are registered as specific purpose funds within the overall charitable fund. Charity Objects 1. Umbrella Charity For any charitable purpose or purposes relating to the National Health Service wholly or mainly for the services provided by the Whittington Hospital NHS Trust 2. The Royal Northern Scheme General Purpose Fund As for the Umbrella Charity GHE Bequest The primary objects being to provide facilities and amenities to patients to relieve suffering and anxiety and to aid recovery. The secondary objects refer to the maintenance and improvement of facilities for fee-paying patients and to subsidise their costs in cases of need as determined by the Trustees Nursing Staff Fund To provide amenities for nursing staff at the Whittington Hospital 3.
    [Show full text]
  • 201819 Master Contract List FINAL 11072018 to Be Added to Website.Xlsx
    Description Provider Start Date End Date Contract Notice Period Diagnostic Services ‐ ISTC InHealth Netcare Ltd 01/07/2014 30/06/2018 12 Months Specialist Pallative Care ST JOSEPHS HOSPICE 01/04/2016 01/03/2019 1 Month Pallative care (Childrens hospice) RICHARD HOUSE TRUST 01/04/2016 31/03/2019 7 Months HIV Services ‐ non consortia MILDMAY MISSION HOSPITAL UK 01/04/2016 31/03/2019 3 Months Newham Urgent Care Centre BARTS HEALTH NHS TRUST 20/11/2013 31/05/2018 ELFT CHS EAST LONDON NHS FOUNDATION TRUST 01/04/2017 31/03/2019 3 Months Mental Health EAST LONDON NHS FOUNDATION TRUST 01/04/2017 31/03/2019 7 Months Acute ‐ In Area SLA ‐ Barts Health BARTS HEALTH NHS TRUST 01/04/2017 31/03/2019 6 Months Acute ‐ In Area SLA ‐ HUH HOMERTON UNIVERSITY HOSPITAL NHS FOUNDATION TRUST 01/04/2017 31/03/2019 6 Months Ambulance Service ‐ Urgent Care LONDON AMBULANCE SERVICE NHS TRUST 01/04/2017 31/03/2019 3 Months Acute ‐ Out of Area ‐ Moorfields MOORFIELDS EYE HOSPITAL NHS FOUNDATION TRUST 01/04/2017 31/03/2019 6 Months Acute ‐ Out of Area ‐ UCLH UNIVERSITY COLLEGE LONDON HOSPITALS NHS FOUNDATION TRUST 01/04/2017 31/03/2019 6 Months Acute ‐ Out of Area ‐ BHRUT BARKING HAVERING AND REDBRIDGE HOSPITALS NHS TRUST 01/04/2017 31/03/2019 6 Months Acute ‐ Out of Area ‐ GST GUYS & ST THOMAS HOSPITAL NHS FOUNDATION TRUST 01/04/2017 31/03/2019 6 Months Acute ‐ Out of Area ‐ ICH IMPERIAL COLLEGE HEALTHCARE NHS TRUST 01/04/2017 31/03/2019 6 Months Acute ‐ Out of Area ‐ C&W CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST 01/04/2017 31/03/2019 6 Months Acute ‐
    [Show full text]
  • Stronger Together
    Stronger Together Prosperity for Aberdeen 2017-2022 Aberdeen City Council Conservative and Unionist Party, Aberdeen Labour and Independent Alliance Group Programme for Aberdeen City Council 2017-2022 Our Vision As a returning coalition, we intend to build on what we have already put in place between 2012 and 2017. The Council’s strategic business plan refresh, approved unanimously at the Council’s Budget meeting in February 2017, agreed the alignment of the Strategic Business Plan to Aberdeen City Community Planning Partnership’s Local Outcome Improvement Plan, as well as alignment to the coalition’s policy document “Smarter Aberdeen”. Our new policy document “Stronger Together” for 2017 to 2022 builds on the 2017-2018 strategic business plan, thereby ensuring the continuity of the priorities we set in our last administration whilst incorporating some new priorities which are a direct response to the changing economic and social conditions the City now faces. We recognise, of course, that our priorities must be delivered within the financial parameters agreed by the Council at the Budget meeting in February 2017. Aberdeen has been the northern powerhouse of both the UK and Scottish economy in recent times, but the fall in the global oil price has seen Aberdeen’s economic contribution reduce. We know the strength of the City’s business community and we commit to working with the business community and all relevant public partners in order to ensure the conditions for future business success are in place within the City. To unlock the economic potential of Aberdeen and reduce inequalities in our city, we see greater devolution of powers to the City from the Scottish government, and where applicable the UK government as a key requirement.
    [Show full text]
  • Programme Final (1).Pages
    BSHS Postgraduate Conference 2015 Programme !1 The British Society for the History of Science is a company limited by guarantee: registration number 562208 and charity number 258854. BSHS Executive Secretary PO Box 3401, Norwich NR7 7JF (+44) 01603516236 Email: offi[email protected] Webpage: www.bshs.org.uk © 2014, British Society for the History of Science !2 BSHS POSTGRADUATE CONFERENCE UCL Department of Science and Technology Studies 7 – 8 – 9 JANUARY 2015 The Department of Science and Technology Studies at University College London welcomes you to the BSHS Postgraduate Conference 2015! This event is an annual conference for postgraduate scholars in the history, philosophy and sociology of science, technology and medicine interested in meeting and sharing research with other postgraduate scholars. This is a great opportunity to build professional and social networks within a supportive and constructive environment. We had an outstanding response for paper submissions and postgraduate attendance, and we are looking forward to an extraordinary conference this year. Thank you for your contribution! Sincerely, BSHS Postgraduate Conference 2015 Committee Elizabeth Jones Raquel Velho Erman Sozudogru !3 " !4 Blue: Grey: Yellow: Grant Museum of Zoology UCL Roberts Building Holiday Inn Bloomsbury 21 University Street Torrington Place Coram Street London WC1E 6DE London WC1E 7JE London WC1N 1HT CONFERENCE INFORMATION Webpage: http://www.bshs.org.uk/conferences/postgraduate-conference/2015- postgraduate-conference-ucl Facebook: https://www.facebook.com/BSHS.PG.15
    [Show full text]
  • Uclpartners Academic Health Science Partnership
    UCLPartners academic health science partnership Professor the Lord Ajay Kakkar, Chair, UCLPartners Professor Sir David Fish, Managing Director, UCLPartners Dr Charlie Davie, Director of UCLPartners AHSN Clare Panniker, Chief Executive, Basildon and Thurrock University Hospitals NHS Foundation Trust What is UCLPartners? Six million population 23 healthcare organisations acute and 11 higher education institutes mental health trusts; community providers and research networks 20 Clinical Commissioning Groups (CCGs) Industry partnerships in research and 26 boroughs and local councils translation of innovation into health and wealth 2 Local Enterprise Partnership – key challenge • Working with the London Enterprise Panel, established by the Mayor of London • Professor Stephen Caddick, Vice Provost (Enterprise), UCL, is the only academic representative on the Panel • Key challenges of the panel: to compete with Boston and San Francisco; improve access to the NHS market to increase venture capital • How UCLPartners is contributing: working with industry to co-create technology and devices; creating long-term partnerships with industry and giving confidence to entrepreneurs, e.g. through new business models and procurement initiatives • Other areas of joint working: MedCity, Care City, London Health Commission, three London AHSNs and preparing to enable the success of the Francis Crick Institute 3 Defragmenting the pathway – an integrated journey to transform healthcare through innovation into practice Bringing together formal designations under
    [Show full text]
  • Aberdeen History Trail the City Through Its Historical Times
    Aberdeen History Trail The city through its historical times #aberdeentrails #aberdeentrails Aberdeen is bursting full of history! From its ancient origins to medieval burghs and King Robert The Bruce, from the Jacobite connections to the expansion in the Edwardian and Victorian times, the ‘Silver City by the Golden Sands’ has a long, important, and interesting history with many of its people contributing to the wider world. The city started out as three separate royal burghs – Old Aberdeen, New Aberdeen and Torry plus the parish of Woodside – which expanded and merged together to form the city as a whole. There was a major expansion in the Georgian, Edwardian and Victorian eras as the city made its first fortunes based on fishing, granite quarrying and shipbuilding and many of the grand buildings were built during these times. It also included the main thoroughfare, Union Street, which was raised up away from the mud and dirt and built on a series of bridges – it was such a major project it almost bankrupted the city! Enjoy exploring our beautiful city and finding out about its history! Picture Credits All images © Aberdeen City Council unless otherwise stated Introduction and all entries: This trail is extensively illustrated by period pictures from the Silver City Vault. The majority are from this source and we’re very grateful for their use and the help from this service. They are all used courtesy of Aberdeen City Libraries/Silver City Vault www.silvercityvault.org.uk 4: Used courtesy of the photographer © Roddy Millar. 14: Thomas Blake Glover courtesy Nagasaki Museum of History and Culture Left, New & Old Aberdeen maps: Details from Parson Gordon’s map of 1661.
    [Show full text]
  • Aberdeen Home Rule Charter
    ABERDEEN HOME RULE CHARTER ADOPTED NOVEMBER 2004 ABERDEEN HOME RULE CHARTER TABLE OF CONTENTS PREAMBLE ………………………………………………………………………………………………………….1 ARTICLE I: POWERS OF THE CITY...................................................................................................................1 SECTION 1.01. POWERS OF THE CITY .................................................................................................................1 SECTION 1.02. CONSTRUCTION ...........................................................................................................................1 SECTION 1.03. INTERGOVERNMENTAL RELATIONS ...........................................................................................1 SECTION 1.04. LIMITATIONS ...............................................................................................................................1 SECTION 1.05. NEW TAXES .................................................................................................................................1 ARTICLE II: CITY COUNCIL................................................................................................................................1 SECTION 2.01. GENERAL POWERS AND DUTIES ....................................................................................................1 SECTION 2.02. COMPOSITION, ELIGIBILITY, ELECTION AND TERMS ...................................................................2 (a) Composition . .............................................................................................................................................2
    [Show full text]
  • UKI NETS 11Th National Conference 25 November 2013 the Royal College of Physicians London, UK
    UKI NETS 11th National Conference 25 November 2013 The Royal College of Physicians London, UK Abstract Marking Panel Alan Anthoney (Leeds, UK) Simon Aylwin (London, UK) Dr Tu Vinh Luong (London, UK) Prakesh Manoharan (Manchester, UK) Nick Reed (Glasgow, UK) UKI NETS would like to thank their sponsors for their kind generosity: Educational Sponsors: Meeting Sponsor: UKI NETS Euro House 22 Apex Court Tel: +44-(0)1454 642277 Woodlands Fax: +44-(0)1454 642222 Bradley Stoke Email: [email protected] Bristol, BS32 4JT, UK Website: www.ukinets.org 2 Contents Pages Programme 4 – 6 Speaker Biographies 7 - 10 Abstracts 12 – 67 3 Programme CPD UKI NETS 11TH NATIONAL CONFERENCE has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 6 category 1 (external) CPD credits. 08:30 Registration, Coffee and Poster viewing 09:25 Welcome and opening remarks Nick Reed (Glasgow, UK) 09:30 – 11:00 Session 1 – Pancreatic NETS –who when and how to intervene? Chair: Graeme Poston 09:30 Imaging assessment of the incidental pancreatic mass Dylan Lewis (London, UK) 09:50 Management of pancreatic primary in presence of metastatic disease Massimo Falconi (Torrette-Ancona, Italy) 10:10 Localisation of insulinoma Karim Meeran (London, UK) 10:30 Surgical approach to the pancreas and parathyroid in patients with MEN1/VHL Barney Harrison (Sheffield, UK) 10:50 Open Floor Q&A 11:00 Coffee, poster viewing and exhibition 11:30 - 12:15 Session 2a – Management dilemmas - Debate – Chemotherapy is first line treatment for pancreatic metastatic
    [Show full text]